..and on this thread..(from Twitter @mesoblast 4:45pm today):
50% of 30,000 patients w/ blood cancer who receive a donor bone marrow transplant develop acute graft versus host disease. The FDA accepted for priority review Mesoblast’s BLA for RYONCIL™ (remestemcel-L) to treat this devastating disease.
Learn more: https://buff.ly/2YFSCwq
MSB Trading - 2020, page-7436
-
- There are more pages in this discussion • 15,725 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12398 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 5440 | 3 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |